Restraining Serum Institute from using the Covishield TM would have larger ramifications

The Bombay HC on 20th April 2021 dealt with an appeal, its subject matter being the trademark ‘Covishield’. Two well-known pharmaceutical companies- Cutis Biotech (Appellant) and Serum Institute of India (Respondent) had applied for registering the TM, their applications pending.  Background: Cutis Biotech commenced in the year 2013 while Serum Institute of India(SII) in 1956.

To Read More Please Subscribe to VIP Membership for Unlimited Access to All the Articles, Download Available Copies of Judgments/Order, Acess to Central/State Bare Acts, Advertisement Free Content, Access to More than 4000 Legal Drafts( Readymade Editable Formats of Suits, Petitions, Writs, Legal Notices, Divorce Petitions, 138 Notices, Bail Applications etc.) in Hindi and English.

Click to Subscribe

If you are already a VIP Member, Click to Login Now